InvestorsHub Logo
Followers 5
Posts 335
Boards Moderated 0
Alias Born 10/11/2018

Re: None

Thursday, 02/29/2024 6:45:56 AM

Thursday, February 29, 2024 6:45:56 AM

Post# of 7354
Been in this for 2 years. Yes, the business is very promising BUT, I've endured more than my share of losses due to dredded R/S's. The SS on PSYC is fine but the company continues the pursuit of a R/S. They don't even word it correctly. They want to do a 1 for 30, but they call it a 30 for 1. Since we are already in short term overbought condition, I'm out if we get to .0052. I'll have a good profit and will see what happens after the split. Besides, they're not even close to profitability yet. $1 mil Assets, $11 mil Liabilities, $100 mil Accumulated Deficit! Do your due diligence. GLTA

On October 10, 2022, the Company’s Board of Directors approved a recapitalization in the form of a 30-to-1 reverse
split. The certificate of amendment was filed and acknowledged by the state of Nevada on October 12, 2022. In
March 2023, the assigned FINRA examiner allowed the time limit associated with the review of the Company’s
recapitalization request to expire. Therefore, the recapitalization was not approved by FINRA and did not become
effective. The Company’s Board of Director’s elected to not pursue an appeal with FINRA.

On August 10, 2023 the Company’s Board of Director’s voted unanimously to resubmit its request for a
recapitalization in the form of a 30-to-1 reverse split with FINRA. The FINRA filing was submitted to FINRA on
August 15, 2023. As of November 13, 2023, the recapitalization request remains under review by the assigned
FINRA examiner.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y